| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | GTF2F1 SAFB TOX3 H1-3 NAP1L3 SMARCC2 MACROH2A2 CHD3 CHD4 CHD6 CHD7 TOX2 MECP2 HMGN3 TOP2A TOP2B | 1.60e-11 | 739 | 50 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | histone binding | 9.21e-10 | 265 | 50 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.06e-09 | 167 | 50 | 8 | GO:0031490 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 6.89e-07 | 67 | 50 | 5 | GO:0031492 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 7.43e-07 | 127 | 50 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.16e-06 | 37 | 50 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.81e-06 | 262 | 50 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | nucleosome binding | 4.57e-06 | 98 | 50 | 5 | GO:0031491 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 3.68e-05 | 4 | 50 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.31e-04 | 614 | 50 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.58e-04 | 42 | 50 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 1.70e-04 | 8 | 50 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.71e-04 | 562 | 50 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.20e-04 | 753 | 50 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | helicase activity | 6.55e-04 | 158 | 50 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.83e-04 | 441 | 50 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.06e-03 | 645 | 50 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.18e-03 | 83 | 50 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.64e-03 | 93 | 50 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.12e-03 | 1160 | 50 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.57e-03 | 229 | 50 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 3.67e-03 | 36 | 50 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.80e-03 | 417 | 50 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 5.95e-03 | 147 | 50 | 3 | GO:0042826 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 5.97e-03 | 1356 | 50 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.92e-03 | 303 | 50 | 4 | GO:0003713 | |
| GeneOntologyBiologicalProcess | chromatin organization | SAFB ARID4A SETD5 RBBP5 H1-3 NAP1L3 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 CHD6 CHD7 MECP2 HMGN3 | 1.78e-09 | 896 | 50 | 15 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SAFB ARID4A SETD5 RBBP5 H1-3 NAP1L3 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 CHD6 CHD7 MECP2 HMGN3 | 7.79e-09 | 999 | 50 | 15 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | ARID4A SETD5 RBBP5 H1-3 NAP1L3 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 CHD6 CHD7 MECP2 | 1.55e-08 | 741 | 50 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 5.76e-06 | 2 | 50 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.38e-05 | 142 | 50 | 5 | GO:0034728 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.83e-04 | 1053 | 50 | 10 | GO:0000122 | |
| GeneOntologyBiologicalProcess | terminal button organization | 2.05e-04 | 9 | 50 | 2 | GO:0072553 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 2.17e-04 | 122 | 50 | 4 | GO:0006334 | |
| GeneOntologyBiologicalProcess | DNA topological change | 2.56e-04 | 10 | 50 | 2 | GO:0006265 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | GTF2F1 SAFB ARID4A TOX3 DAXX CHD6 CHD7 TOX2 MECP2 HMGN3 TOP2A | 4.06e-04 | 1390 | 50 | 11 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ARID4A SETD5 TRO H1-3 PHF6 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 MECP2 | 4.29e-04 | 1399 | 50 | 11 | GO:0045892 |
| GeneOntologyBiologicalProcess | DNA damage response | 4.39e-04 | 959 | 50 | 9 | GO:0006974 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ARID4A SETD5 TRO H1-3 PHF6 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 MECP2 | 4.67e-04 | 1413 | 50 | 11 | GO:1902679 |
| GeneOntologyCellularComponent | chromatin | PDS5B ARID4A SETD5 H1-3 NAP1L3 NKX1-1 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 CHD6 CHD7 MECP2 HMGN3 CREBL2 TOP2B | 1.33e-08 | 1480 | 48 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | histone deacetylase complex | 4.32e-05 | 85 | 48 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | chromosomal region | 4.62e-05 | 421 | 48 | 7 | GO:0098687 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 4.17e-04 | 276 | 48 | 5 | GO:0000775 | |
| GeneOntologyCellularComponent | NuRD complex | 6.87e-04 | 17 | 48 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 6.87e-04 | 17 | 48 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.38e-03 | 24 | 48 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.40e-03 | 96 | 48 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | heterochromatin | 1.62e-03 | 101 | 48 | 3 | GO:0000792 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.72e-03 | 254 | 48 | 4 | GO:0000228 | |
| GeneOntologyCellularComponent | PML body | 2.97e-03 | 125 | 48 | 3 | GO:0016605 | |
| GeneOntologyCellularComponent | ATPase complex | 3.24e-03 | 129 | 48 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | sex chromosome | 4.59e-03 | 44 | 48 | 2 | GO:0000803 | |
| MousePheno | absent nasal pit | 2.15e-05 | 3 | 38 | 2 | MP:0030060 | |
| Domain | CHROMO | 2.49e-10 | 33 | 49 | 6 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.49e-10 | 33 | 49 | 6 | IPR000953 | |
| Domain | Chromodomain-like | 1.92e-08 | 32 | 49 | 5 | IPR016197 | |
| Domain | Chromo_domain | 4.27e-07 | 24 | 49 | 4 | IPR023780 | |
| Domain | Chromo | 5.99e-07 | 26 | 49 | 4 | PF00385 | |
| Domain | CHROMO_2 | 8.17e-07 | 28 | 49 | 4 | PS50013 | |
| Domain | CHROMO_1 | 8.17e-07 | 28 | 49 | 4 | PS00598 | |
| Domain | SNF2_N | 1.42e-06 | 32 | 49 | 4 | PF00176 | |
| Domain | SNF2_N | 1.42e-06 | 32 | 49 | 4 | IPR000330 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.06e-06 | 35 | 49 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.89e-06 | 38 | 49 | 4 | PS00690 | |
| Domain | TOPRIM_C | 6.74e-06 | 2 | 49 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 6.74e-06 | 2 | 49 | 2 | PF16898 | |
| Domain | - | 6.74e-06 | 2 | 49 | 2 | 3.90.199.10 | |
| Domain | DNA_topoisoIV | 6.74e-06 | 2 | 49 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 6.74e-06 | 2 | 49 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 6.74e-06 | 2 | 49 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 6.74e-06 | 2 | 49 | 2 | IPR013759 | |
| Domain | - | 6.74e-06 | 2 | 49 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 6.74e-06 | 2 | 49 | 2 | IPR012542 | |
| Domain | TopoIIA_CS | 6.74e-06 | 2 | 49 | 2 | IPR018522 | |
| Domain | TOP4c | 6.74e-06 | 2 | 49 | 2 | SM00434 | |
| Domain | TOP2c | 6.74e-06 | 2 | 49 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 6.74e-06 | 2 | 49 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 6.74e-06 | 2 | 49 | 2 | IPR013506 | |
| Domain | DTHCT | 6.74e-06 | 2 | 49 | 2 | PF08070 | |
| Domain | DNA_gyraseB | 6.74e-06 | 2 | 49 | 2 | PF00204 | |
| Domain | - | 6.74e-06 | 2 | 49 | 2 | 1.10.268.10 | |
| Domain | Topo_IIA_A/C | 6.74e-06 | 2 | 49 | 2 | IPR002205 | |
| Domain | Topo_IIA | 6.74e-06 | 2 | 49 | 2 | IPR001241 | |
| Domain | TOPOISOMERASE_II | 6.74e-06 | 2 | 49 | 2 | PS00177 | |
| Domain | - | 2.02e-05 | 3 | 49 | 2 | 3.30.1360.40 | |
| Domain | CHDCT2 | 2.02e-05 | 3 | 49 | 2 | PF08074 | |
| Domain | CHDNT | 2.02e-05 | 3 | 49 | 2 | PF08073 | |
| Domain | DUF1086 | 2.02e-05 | 3 | 49 | 2 | IPR009462 | |
| Domain | DUF1087 | 2.02e-05 | 3 | 49 | 2 | IPR009463 | |
| Domain | DUF1087 | 2.02e-05 | 3 | 49 | 2 | PF06465 | |
| Domain | DUF1086 | 2.02e-05 | 3 | 49 | 2 | PF06461 | |
| Domain | DUF1087 | 2.02e-05 | 3 | 49 | 2 | SM01147 | |
| Domain | DUF1086 | 2.02e-05 | 3 | 49 | 2 | SM01146 | |
| Domain | Arg_repress_C-like | 2.02e-05 | 3 | 49 | 2 | IPR024946 | |
| Domain | CHD_N | 2.02e-05 | 3 | 49 | 2 | IPR012958 | |
| Domain | CHD_C2 | 2.02e-05 | 3 | 49 | 2 | IPR012957 | |
| Domain | HMG_box_dom | 2.52e-05 | 65 | 49 | 4 | IPR009071 | |
| Domain | TOPRIM | 4.03e-05 | 4 | 49 | 2 | PS50880 | |
| Domain | Toprim_domain | 4.03e-05 | 4 | 49 | 2 | IPR006171 | |
| Domain | Toprim | 4.03e-05 | 4 | 49 | 2 | PF01751 | |
| Domain | PHD | 8.66e-05 | 89 | 49 | 4 | SM00249 | |
| Domain | Znf_PHD | 9.45e-05 | 91 | 49 | 4 | IPR001965 | |
| Domain | BRK | 1.00e-04 | 6 | 49 | 2 | SM00592 | |
| Domain | BRK_domain | 1.00e-04 | 6 | 49 | 2 | IPR006576 | |
| Domain | BRK | 1.00e-04 | 6 | 49 | 2 | PF07533 | |
| Domain | ZF_PHD_2 | 1.12e-04 | 95 | 49 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.16e-04 | 96 | 49 | 4 | PS01359 | |
| Domain | Helicase_C | 1.77e-04 | 107 | 49 | 4 | PF00271 | |
| Domain | HELICc | 1.77e-04 | 107 | 49 | 4 | SM00490 | |
| Domain | Helicase_C | 1.83e-04 | 108 | 49 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.90e-04 | 109 | 49 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.90e-04 | 109 | 49 | 4 | PS51192 | |
| Domain | DEXDc | 1.90e-04 | 109 | 49 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.97e-04 | 110 | 49 | 4 | IPR014001 | |
| Domain | SANT | 3.05e-04 | 50 | 49 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.43e-04 | 52 | 49 | 3 | IPR001005 | |
| Domain | - | 4.04e-04 | 55 | 49 | 3 | 1.10.30.10 | |
| Domain | HATPase_c | 1.00e-03 | 18 | 49 | 2 | SM00387 | |
| Domain | HATPase_c | 1.12e-03 | 19 | 49 | 2 | PF02518 | |
| Domain | - | 1.24e-03 | 20 | 49 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 1.37e-03 | 21 | 49 | 2 | IPR003594 | |
| Domain | - | 1.37e-03 | 21 | 49 | 2 | 3.30.230.10 | |
| Domain | EPHD | 1.51e-03 | 22 | 49 | 2 | PS51805 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 1.51e-03 | 22 | 49 | 2 | IPR014721 | |
| Domain | AT_hook | 2.27e-03 | 27 | 49 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.27e-03 | 27 | 49 | 2 | IPR017956 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.99e-05 | 175 | 33 | 5 | MM14941 | |
| Pathway | REACTOME_SUMOYLATION | 7.19e-05 | 189 | 33 | 5 | M27214 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 2.36e-04 | 10 | 33 | 2 | M7239 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.82e-04 | 55 | 33 | 3 | MM14932 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 2.88e-04 | 11 | 33 | 2 | MM1349 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.93e-04 | 272 | 33 | 5 | M29619 | |
| Pathway | REACTOME_SUMOYLATION | 6.22e-04 | 169 | 33 | 4 | MM14919 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B ARID4A RBBP5 ZBTB40 SMARCC2 DAXX CHD3 CHD4 CHD6 CHD7 MECP2 TOP2A TOP2B RAI1 LRRC41 | 4.70e-15 | 608 | 50 | 15 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B SAFB TCOF1 ARID4A ZBTB40 SMARCC2 DAXX CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B ADD1 | 2.91e-12 | 774 | 50 | 14 | 15302935 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | PDS5B SETD5 H1-3 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 MECP2 HMGN3 TOP2A TOP2B | 1.06e-11 | 533 | 50 | 12 | 30554943 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B SAFB PDE6H ARID4A SURF6 PHF6 SMARCC2 CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B RAI1 | 4.65e-11 | 954 | 50 | 14 | 36373674 |
| Pubmed | PDS5B SNIP1 IBTK H1-3 SMARCC2 CHD3 CHD6 CHD7 MECP2 TOP2A TOP2B | 5.55e-11 | 469 | 50 | 11 | 27634302 | |
| Pubmed | 1.46e-10 | 103 | 50 | 7 | 32744500 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SNIP1 SAFB TCOF1 ARID4A RBBP5 SURF6 CHD3 CHD4 CHD6 CHD7 MECP2 HMGN3 TOP2A TOP2B RAI1 | 2.21e-10 | 1294 | 50 | 15 | 30804502 |
| Pubmed | PDS5B SAFB SETD5 TRO H1-3 SMARCC2 CHD3 CHD4 CHD6 MECP2 HMGN3 TOP2A TOP2B RAI1 CFAP46 | 9.81e-10 | 1442 | 50 | 15 | 35575683 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 9.95e-10 | 330 | 50 | 9 | 33301849 | |
| Pubmed | 2.72e-09 | 251 | 50 | 8 | 31076518 | ||
| Pubmed | PDS5B GTF2F1 SAFB ZBTB40 PHF6 SMARCC2 CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B RAI1 | 3.66e-09 | 1103 | 50 | 13 | 34189442 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.67e-09 | 394 | 50 | 9 | 27248496 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ARID4A RBBP5 TRO ZBTB40 SMARCC2 MACROH2A2 CHD4 MECP2 TOP2A TOP2B LRRC41 | 2.97e-08 | 857 | 50 | 11 | 25609649 |
| Pubmed | SNIP1 TCOF1 SETD5 SURF6 SMARCC2 MACROH2A2 CHD3 CHD4 MECP2 TOP2A RAI1 LRRC41 | 4.43e-08 | 1116 | 50 | 12 | 31753913 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 7.30e-08 | 148 | 50 | 6 | 32538781 | |
| Pubmed | 1.43e-07 | 419 | 50 | 8 | 15635413 | ||
| Pubmed | PDS5B GTF2F1 SAFB RBBP5 PHF6 SMARCC2 CHD3 CHD4 HMGN3 TOP2A TOP2B | 1.62e-07 | 1014 | 50 | 11 | 32416067 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.82e-07 | 605 | 50 | 9 | 28977666 | |
| Pubmed | 2.11e-07 | 441 | 50 | 8 | 31239290 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PDS5B SNIP1 SAFB TCOF1 H1-3 PHF6 CHD4 CHD6 CHD7 TOP2A TOP2B ADD1 | 2.67e-07 | 1318 | 50 | 12 | 30463901 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDS5B SAFB TCOF1 SURF6 SMARCC2 MACROH2A2 CHD4 CHD6 CHD7 MECP2 TOP2B | 3.09e-07 | 1082 | 50 | 11 | 38697112 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 4.71e-07 | 203 | 50 | 6 | 22083510 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 6.65e-07 | 349 | 50 | 7 | 25665578 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.22e-07 | 934 | 50 | 10 | 33916271 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.21e-06 | 759 | 50 | 9 | 35915203 | |
| Pubmed | 1.58e-06 | 250 | 50 | 6 | 33536335 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B SAFB TCOF1 SMARCC2 MACROH2A2 CHD3 CHD4 TOP2A TOP2B KRT80 | 1.65e-06 | 1024 | 50 | 10 | 24711643 |
| Pubmed | 1.85e-06 | 407 | 50 | 7 | 12693553 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.94e-06 | 259 | 50 | 6 | 30404004 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.97e-06 | 411 | 50 | 7 | 35182466 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24048577 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 32218491 | ||
| Pubmed | CHD chromatin remodelling enzymes and the DNA damage response. | 2.03e-06 | 2 | 50 | 2 | 23954449 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 2.03e-06 | 2 | 50 | 2 | 7560064 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 1309226 | ||
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 2.03e-06 | 2 | 50 | 2 | 19222228 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 2555055 | ||
| Pubmed | Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. | 2.03e-06 | 2 | 50 | 2 | 23399433 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30169847 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 1331984 | ||
| Pubmed | Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells. | 2.03e-06 | 2 | 50 | 2 | 15044480 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17526531 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31106979 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16091284 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9155056 | ||
| Pubmed | Kinetic analysis of human topoisomerase IIalpha and beta DNA binding by surface plasmon resonance. | 2.03e-06 | 2 | 50 | 2 | 14596941 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17361331 | ||
| Pubmed | DNA topoisomerase II distribution in mouse preimplantation embryos. | 2.03e-06 | 2 | 50 | 2 | 11835579 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10095062 | ||
| Pubmed | Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. | 2.03e-06 | 2 | 50 | 2 | 14996935 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 2556712 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16712776 | ||
| Pubmed | Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms. | 2.03e-06 | 2 | 50 | 2 | 8710863 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9795238 | ||
| Pubmed | The distribution of DNA topoisomerase II isoforms in differentiated adult mouse tissues. | 2.03e-06 | 2 | 50 | 2 | 8241259 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 32535049 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26612825 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10473615 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 1380833 | ||
| Pubmed | CHD6 is a DNA-dependent ATPase and localizes at nuclear sites of mRNA synthesis. | 2.03e-06 | 2 | 50 | 2 | 17027977 | |
| Pubmed | Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. | 2.03e-06 | 2 | 50 | 2 | 11927602 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17182034 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 2.03e-06 | 2 | 50 | 2 | 35568926 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9224616 | ||
| Pubmed | DNA damage response during chromatin remodeling in elongating spermatids of mice. | 2.03e-06 | 2 | 50 | 2 | 18032420 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8299728 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22111588 | ||
| Pubmed | Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. | 2.03e-06 | 2 | 50 | 2 | 17578914 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 7575689 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28700616 | ||
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 2.03e-06 | 2 | 50 | 2 | 8843877 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28087392 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 28472494 | ||
| Pubmed | 2.37e-06 | 268 | 50 | 6 | 33640491 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.52e-06 | 271 | 50 | 6 | 32433965 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 2.70e-06 | 431 | 50 | 7 | 33660365 | |
| Pubmed | 2.96e-06 | 847 | 50 | 9 | 35850772 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.09e-06 | 440 | 50 | 7 | 34244565 | |
| Pubmed | 3.16e-06 | 157 | 50 | 5 | 30186101 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.24e-06 | 283 | 50 | 6 | 30585729 | |
| Pubmed | 3.34e-06 | 638 | 50 | 8 | 31182584 | ||
| Pubmed | 3.62e-06 | 72 | 50 | 4 | 31248990 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 3.80e-06 | 163 | 50 | 5 | 22113938 | |
| Pubmed | 3.96e-06 | 653 | 50 | 8 | 22586326 | ||
| Pubmed | 4.29e-06 | 660 | 50 | 8 | 32780723 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 4.66e-06 | 170 | 50 | 5 | 16159877 | |
| Pubmed | 4.98e-06 | 78 | 50 | 4 | 28611094 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23466610 | ||
| Pubmed | Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1. | 6.07e-06 | 3 | 50 | 2 | 17567603 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11136718 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 22500635 | ||
| Pubmed | Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53. | 6.07e-06 | 3 | 50 | 2 | 10666337 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 32658897 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 36633090 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16611985 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31474762 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 28533432 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24808172 | ||
| Pubmed | Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta. | 6.07e-06 | 3 | 50 | 2 | 12821127 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9049244 | ||
| Interaction | H2BC8 interactions | PDS5B GTF2F1 ARID4A RBBP5 PHF6 SMARCC2 MACROH2A2 CHD3 CHD4 CHD6 CHD7 MECP2 TOP2A TOP2B RAI1 LRRC41 | 3.23e-13 | 576 | 50 | 16 | int:H2BC8 |
| Interaction | BRD3 interactions | PDS5B SNIP1 SETD5 SURF6 H1-3 SMARCC2 DAXX MACROH2A2 CHD4 MECP2 HMGN3 TOP2A TOP2B RAI1 | 9.85e-12 | 494 | 50 | 14 | int:BRD3 |
| Interaction | H3C3 interactions | PDS5B ARID4A RBBP5 SMARCC2 DAXX CHD3 CHD4 CHD6 CHD7 MECP2 TOP2A TOP2B RAI1 LRRC41 | 1.01e-11 | 495 | 50 | 14 | int:H3C3 |
| Interaction | H2BC21 interactions | PDS5B ARID4A RBBP5 H1-3 SMARCC2 DAXX MACROH2A2 CHD4 CHD7 MECP2 HMGN3 TOP2A TOP2B RAI1 CFAP46 | 7.48e-11 | 696 | 50 | 15 | int:H2BC21 |
| Interaction | ZNF330 interactions | PDS5B GTF2F1 SURF6 PHF6 SMARCC2 CHD3 CHD7 MECP2 TOP2A TOP2B RAI1 LRRC41 | 6.76e-10 | 446 | 50 | 12 | int:ZNF330 |
| Interaction | H3-3A interactions | PDS5B RBBP5 H1-3 ZBTB40 SMARCC2 DAXX CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B RAI1 LRRC41 | 2.30e-09 | 749 | 50 | 14 | int:H3-3A |
| Interaction | GLYR1 interactions | 6.55e-09 | 239 | 50 | 9 | int:GLYR1 | |
| Interaction | COIL interactions | PDS5B GTF2F1 PHF6 DAXX CHD3 CHD4 CHD6 CHD7 MECP2 TOP2A TOP2B LRRC41 | 7.44e-09 | 552 | 50 | 12 | int:COIL |
| Interaction | SRRM1 interactions | 1.15e-08 | 348 | 50 | 10 | int:SRRM1 | |
| Interaction | POU5F1 interactions | IBTK TCOF1 RBBP5 H1-3 SMARCC2 CHD3 CHD4 CHD7 TOX2 TOP2A TOP2B LRRC41 | 1.39e-08 | 584 | 50 | 12 | int:POU5F1 |
| Interaction | PYHIN1 interactions | 1.51e-08 | 358 | 50 | 10 | int:PYHIN1 | |
| Interaction | ARID1A interactions | 2.28e-08 | 276 | 50 | 9 | int:ARID1A | |
| Interaction | CENPA interactions | 2.46e-08 | 377 | 50 | 10 | int:CENPA | |
| Interaction | FBL interactions | TCOF1 NEIL1 TRO SURF6 NAP1L3 PHF6 CHD3 CHD4 MECP2 TOP2A TOP2B LRRC41 | 3.75e-08 | 639 | 50 | 12 | int:FBL |
| Interaction | CHD4 interactions | SNIP1 SAFB TCOF1 PHF6 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 MECP2 TOP2A TOP2B RAI1 KRT80 | 3.98e-08 | 938 | 50 | 14 | int:CHD4 |
| Interaction | H2BC3 interactions | 4.94e-08 | 406 | 50 | 10 | int:H2BC3 | |
| Interaction | PARP1 interactions | PDS5B GTF2F1 H1-3 PHF6 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 CHD6 CHD7 MECP2 TOP2A TOP2B RAI1 KRT80 | 5.91e-08 | 1316 | 50 | 16 | int:PARP1 |
| Interaction | SSRP1 interactions | SNIP1 SAFB SETD5 RBBP5 DAXX MACROH2A2 CHD3 CHD4 MECP2 TOP2A TOP2B RAI1 | 8.02e-08 | 685 | 50 | 12 | int:SSRP1 |
| Interaction | H2BC12 interactions | 8.55e-08 | 322 | 50 | 9 | int:H2BC12 | |
| Interaction | SMC5 interactions | PDS5B SAFB PDE6H ARID4A SURF6 PHF6 SMARCC2 CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B RAI1 | 8.81e-08 | 1000 | 50 | 14 | int:SMC5 |
| Interaction | RFC1 interactions | 9.36e-08 | 231 | 50 | 8 | int:RFC1 | |
| Interaction | TOP1 interactions | GTF2F1 SAFB TCOF1 RBBP5 SMARCC2 MACROH2A2 CHD3 CHD4 MECP2 TOP2A TOP2B RAI1 | 9.54e-08 | 696 | 50 | 12 | int:TOP1 |
| Interaction | NOP56 interactions | IBTK GTF2F1 TCOF1 NEIL1 SURF6 H1-3 CHD3 CHD4 MECP2 TOP2A TOP2B | 1.16e-07 | 570 | 50 | 11 | int:NOP56 |
| Interaction | H2BC9 interactions | 1.19e-07 | 446 | 50 | 10 | int:H2BC9 | |
| Interaction | RBBP4 interactions | SAFB ARID4A RBBP5 PHF6 SMARCC2 CHD3 CHD4 CHD7 MECP2 TOP2A RAI1 | 1.22e-07 | 573 | 50 | 11 | int:RBBP4 |
| Interaction | ZBTB2 interactions | 1.29e-07 | 450 | 50 | 10 | int:ZBTB2 | |
| Interaction | NOC3L interactions | 1.43e-07 | 244 | 50 | 8 | int:NOC3L | |
| Interaction | SMARCC2 interactions | 1.87e-07 | 353 | 50 | 9 | int:SMARCC2 | |
| Interaction | H3C1 interactions | PDS5B GTF2F1 RBBP5 H1-3 SMARCC2 DAXX MACROH2A2 CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B | 1.99e-07 | 901 | 50 | 13 | int:H3C1 |
| Interaction | DDX23 interactions | 2.34e-07 | 480 | 50 | 10 | int:DDX23 | |
| Interaction | REXO4 interactions | 2.39e-07 | 261 | 50 | 8 | int:REXO4 | |
| Interaction | APEX1 interactions | PDS5B GTF2F1 SAFB TCOF1 ARID4A NEIL1 SURF6 SMARCC2 DAXX CHD4 CHD7 MECP2 TOP2B RAI1 LRRC41 | 2.53e-07 | 1271 | 50 | 15 | int:APEX1 |
| Interaction | RBM28 interactions | 2.65e-07 | 368 | 50 | 9 | int:RBM28 | |
| Interaction | POLR1G interactions | PDS5B GTF2F1 TCOF1 SURF6 SMARCC2 CHD7 MECP2 TOP2A TOP2B RAI1 | 2.78e-07 | 489 | 50 | 10 | int:POLR1G |
| Interaction | H2AZ1 interactions | 2.84e-07 | 371 | 50 | 9 | int:H2AZ1 | |
| Interaction | NUP43 interactions | PDS5B SAFB ARID4A RBBP5 SURF6 TOX3 CHD3 CHD6 MECP2 TOP2A TOP2B | 2.91e-07 | 625 | 50 | 11 | int:NUP43 |
| Interaction | GNL2 interactions | 3.96e-07 | 386 | 50 | 9 | int:GNL2 | |
| Interaction | DKC1 interactions | 4.60e-07 | 393 | 50 | 9 | int:DKC1 | |
| Interaction | SMARCE1 interactions | 4.91e-07 | 287 | 50 | 8 | int:SMARCE1 | |
| Interaction | HMGA1 interactions | 7.85e-07 | 419 | 50 | 9 | int:HMGA1 | |
| Interaction | H2BC13 interactions | 8.25e-07 | 210 | 50 | 7 | int:H2BC13 | |
| Interaction | BRD2 interactions | 9.55e-07 | 429 | 50 | 9 | int:BRD2 | |
| Interaction | HDAC2 interactions | ARID4A RBBP5 H1-3 SMARCC2 DAXX CHD3 CHD4 MECP2 TOP2A TOP2B RAI1 KRT80 | 9.75e-07 | 865 | 50 | 12 | int:HDAC2 |
| Interaction | NIFK interactions | 9.92e-07 | 431 | 50 | 9 | int:NIFK | |
| Interaction | KLHL20 interactions | 9.96e-07 | 216 | 50 | 7 | int:KLHL20 | |
| Interaction | BMS1 interactions | 1.06e-06 | 218 | 50 | 7 | int:BMS1 | |
| Interaction | NUCKS1 interactions | 1.13e-06 | 220 | 50 | 7 | int:NUCKS1 | |
| Interaction | ZC3H18 interactions | SNIP1 SAFB TCOF1 NEIL1 SURF6 H1-3 DAXX MACROH2A2 CHD3 CHD4 MECP2 TOP2A | 1.13e-06 | 877 | 50 | 12 | int:ZC3H18 |
| Interaction | SUPT16H interactions | 1.22e-06 | 442 | 50 | 9 | int:SUPT16H | |
| Interaction | KRI1 interactions | 1.31e-06 | 225 | 50 | 7 | int:KRI1 | |
| Interaction | NLE1 interactions | 1.43e-06 | 228 | 50 | 7 | int:NLE1 | |
| Interaction | PPAN-P2RY11 interactions | 1.47e-06 | 144 | 50 | 6 | int:PPAN-P2RY11 | |
| Interaction | DDX18 interactions | 1.53e-06 | 334 | 50 | 8 | int:DDX18 | |
| Interaction | SMARCA4 interactions | 1.76e-06 | 462 | 50 | 9 | int:SMARCA4 | |
| Interaction | CHD3 interactions | SAFB RBBP5 PHF6 SMARCC2 CHD3 CHD4 CHD6 TOP2A TOP2B RAI1 KRT80 | 1.91e-06 | 757 | 50 | 11 | int:CHD3 |
| Interaction | RPL23A interactions | 1.95e-06 | 606 | 50 | 10 | int:RPL23A | |
| Interaction | SMARCA2 interactions | 1.99e-06 | 346 | 50 | 8 | int:SMARCA2 | |
| Interaction | CSNK2A1 interactions | GTF2F1 SAFB TCOF1 RBBP5 NEIL1 SURF6 SMARCC2 DAXX CHD3 CHD4 MECP2 TOP2A | 2.77e-06 | 956 | 50 | 12 | int:CSNK2A1 |
| Interaction | SMARCB1 interactions | 2.90e-06 | 364 | 50 | 8 | int:SMARCB1 | |
| Interaction | HNRNPC interactions | 2.92e-06 | 634 | 50 | 10 | int:HNRNPC | |
| Interaction | PUM3 interactions | 2.93e-06 | 254 | 50 | 7 | int:PUM3 | |
| Interaction | H2AC4 interactions | 3.70e-06 | 506 | 50 | 9 | int:H2AC4 | |
| Interaction | RBBP7 interactions | 3.76e-06 | 507 | 50 | 9 | int:RBBP7 | |
| Interaction | DCAF4 interactions | 3.84e-06 | 378 | 50 | 8 | int:DCAF4 | |
| Interaction | TOP2B interactions | 3.97e-06 | 266 | 50 | 7 | int:TOP2B | |
| Interaction | CPSF2 interactions | 4.26e-06 | 173 | 50 | 6 | int:CPSF2 | |
| Interaction | SMARCC1 interactions | 4.31e-06 | 384 | 50 | 8 | int:SMARCC1 | |
| Interaction | SF3B2 interactions | 4.41e-06 | 517 | 50 | 9 | int:SF3B2 | |
| Interaction | PHF14 interactions | 4.83e-06 | 100 | 50 | 5 | int:PHF14 | |
| Interaction | RPL31 interactions | 5.43e-06 | 680 | 50 | 10 | int:RPL31 | |
| Interaction | SMARCD2 interactions | 5.89e-06 | 183 | 50 | 6 | int:SMARCD2 | |
| Interaction | RBBP5 interactions | 6.53e-06 | 287 | 50 | 7 | int:RBBP5 | |
| Interaction | RPLP2 interactions | 6.84e-06 | 409 | 50 | 8 | int:RPLP2 | |
| Interaction | DDX51 interactions | 7.04e-06 | 108 | 50 | 5 | int:DDX51 | |
| Interaction | CEBPA interactions | PDS5B GTF2F1 SAFB ZBTB40 PHF6 SMARCC2 CHD3 CHD4 CHD7 MECP2 TOP2A TOP2B RAI1 | 7.42e-06 | 1245 | 50 | 13 | int:CEBPA |
| Interaction | TERF2IP interactions | 7.49e-06 | 552 | 50 | 9 | int:TERF2IP | |
| Interaction | RPS6 interactions | PDS5B SNIP1 SURF6 PHF6 DAXX CHD3 CHD4 CHD6 MECP2 TOP2A TOP2B | 7.58e-06 | 874 | 50 | 11 | int:RPS6 |
| Interaction | SRPK2 interactions | SNIP1 SAFB TCOF1 NEIL1 SURF6 PHF6 MACROH2A2 HMGN3 TOP2A TOP2B | 8.64e-06 | 717 | 50 | 10 | int:SRPK2 |
| Interaction | DDX21 interactions | 8.75e-06 | 718 | 50 | 10 | int:DDX21 | |
| Interaction | NAT10 interactions | 9.10e-06 | 302 | 50 | 7 | int:NAT10 | |
| Interaction | H3-5 interactions | 9.17e-06 | 114 | 50 | 5 | int:H3-5 | |
| Interaction | SAP18 interactions | 9.71e-06 | 305 | 50 | 7 | int:SAP18 | |
| Interaction | RPL27 interactions | 1.00e-05 | 431 | 50 | 8 | int:RPL27 | |
| Interaction | MTA2 interactions | 1.07e-05 | 435 | 50 | 8 | int:MTA2 | |
| Interaction | BAZ1B interactions | 1.10e-05 | 204 | 50 | 6 | int:BAZ1B | |
| Interaction | RPL22 interactions | 1.16e-05 | 440 | 50 | 8 | int:RPL22 | |
| Interaction | NUMA1 interactions | 1.84e-05 | 469 | 50 | 8 | int:NUMA1 | |
| Interaction | RPS17 interactions | 1.85e-05 | 337 | 50 | 7 | int:RPS17 | |
| Interaction | GATAD2A interactions | 1.86e-05 | 224 | 50 | 6 | int:GATAD2A | |
| Interaction | RPF1 interactions | 1.87e-05 | 132 | 50 | 5 | int:RPF1 | |
| Interaction | CSNK2B interactions | 2.01e-05 | 625 | 50 | 9 | int:CSNK2B | |
| Interaction | PRC1 interactions | PDS5B IQCA1L SAFB KIF3B H1-3 MACROH2A2 CHD4 MECP2 HMGN3 TOP2A TOP2B | 2.07e-05 | 973 | 50 | 11 | int:PRC1 |
| Interaction | MYCN interactions | PDS5B SNIP1 SAFB TCOF1 SURF6 PHF6 SMARCC2 DAXX MACROH2A2 CHD4 CHD7 MECP2 RAI1 | 2.12e-05 | 1373 | 50 | 13 | int:MYCN |
| Interaction | RSL1D1 interactions | 2.15e-05 | 479 | 50 | 8 | int:RSL1D1 | |
| Interaction | UTP14A interactions | 2.16e-05 | 230 | 50 | 6 | int:UTP14A | |
| Interaction | NAA40 interactions | 2.17e-05 | 978 | 50 | 11 | int:NAA40 | |
| Interaction | TENT4B interactions | 2.32e-05 | 138 | 50 | 5 | int:TENT4B | |
| Interaction | RPL6 interactions | 2.34e-05 | 637 | 50 | 9 | int:RPL6 | |
| Interaction | SNRNP40 interactions | 2.34e-05 | 637 | 50 | 9 | int:SNRNP40 | |
| Interaction | DOT1L interactions | 2.40e-05 | 807 | 50 | 10 | int:DOT1L | |
| Cytoband | 12p13 | 4.83e-05 | 64 | 50 | 3 | 12p13 | |
| Cytoband | 6q14.1 | 3.16e-04 | 24 | 50 | 2 | 6q14.1 | |
| GeneFamily | Topoisomerases | 4.25e-05 | 6 | 31 | 2 | 1050 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.01e-04 | 53 | 31 | 3 | 532 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.86e-04 | 12 | 31 | 2 | 1305 | |
| GeneFamily | PHD finger proteins | 4.85e-04 | 90 | 31 | 3 | 88 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 1.03e-07 | 200 | 50 | 7 | M9258 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 2.14e-06 | 199 | 50 | 6 | M9255 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 9.01e-06 | 595 | 50 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.40e-05 | 629 | 50 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.74e-05 | 564 | 50 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 7.92e-05 | 979 | 50 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.14e-04 | 203 | 50 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.33e-04 | 210 | 50 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.88e-04 | 248 | 50 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 3.61e-05 | 166 | 50 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 50 | 4 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 50 | 4 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 182 | 50 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.16e-05 | 182 | 50 | 4 | 6c9a48037fa002bc528875538bdaaf15696d68b6 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 182 | 50 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 185 | 50 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 6.48e-05 | 193 | 50 | 4 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.01e-05 | 197 | 50 | 4 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.01e-05 | 197 | 50 | 4 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 7.29e-05 | 199 | 50 | 4 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.29e-05 | 199 | 50 | 4 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.29e-05 | 199 | 50 | 4 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| Drug | DB08184 | 1.53e-06 | 167 | 49 | 6 | CID009547945 | |
| Drug | Dexrazoxane | 4.54e-06 | 2 | 49 | 2 | DB00380 | |
| Drug | F14512 | 4.54e-06 | 2 | 49 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 4.54e-06 | 2 | 49 | 2 | DB00694 | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.85e-05 | 166 | 49 | 5 | 5324_UP | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 8.80e-07 | 12 | 48 | 3 | DOID:9119 (implicated_via_orthology) | |
| Disease | B cell deficiency (implicated_via_orthology) | 2.59e-06 | 2 | 48 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.41e-05 | 7 | 48 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.96e-04 | 69 | 48 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 2.00e-04 | 13 | 48 | 2 | C0265338 | |
| Disease | Adrenocortical carcinoma | 3.90e-04 | 18 | 48 | 2 | C0206686 | |
| Disease | Intellectual Disability | 7.82e-04 | 447 | 48 | 5 | C3714756 | |
| Disease | Child Development Disorders, Specific | 1.02e-03 | 29 | 48 | 2 | C0085997 | |
| Disease | Child Development Deviations | 1.02e-03 | 29 | 48 | 2 | C0085996 | |
| Disease | Developmental Disabilities | 1.09e-03 | 30 | 48 | 2 | C0008073 | |
| Disease | Mental Retardation, Psychosocial | 1.52e-03 | 139 | 48 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 1.52e-03 | 139 | 48 | 3 | C0020796 | |
| Disease | Mental deficiency | 1.52e-03 | 139 | 48 | 3 | C0917816 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEKSPKGKGRRSKTK | 786 | P29374 | |
| KPKHSSPGKKPAGRK | 371 | A8MYA2 | |
| SGKKGGKKSKAAKPR | 141 | Q9P0M6 | |
| KKRSLAKKGRKGSIP | 2386 | Q8IYW2 | |
| SAPVPRGRKGKKVKA | 1686 | Q9P2D1 | |
| GPPCKKSRKEKKQTG | 626 | Q9UER7 | |
| AFKSGKRVGKPSPKA | 1091 | Q7Z5J4 | |
| SKKGSKKKSGPPAPE | 1311 | Q9NTI5 | |
| GPLAPKGRKSRKKKS | 286 | Q96FI4 | |
| KKKKSGSEKNTGRPP | 201 | Q9UBI9 | |
| KAKKKPRKRSDSSGG | 981 | Q9P2D0 | |
| APSRKKKGSKGPVIK | 421 | Q6KB66 | |
| GKGKPKPKVPERKSS | 881 | Q5SYE7 | |
| AGGTPRAAPKKRRKK | 86 | Q12796 | |
| PKPRKTSAKKEPGAK | 41 | Q15651 | |
| PGKKICRKGGPLTKK | 176 | Q8N2Q7 | |
| RPKGSKGKEKDSPFK | 486 | Q15291 | |
| GAAKGSKDREPKPKR | 106 | Q8TD26 | |
| KEGKGPGHKRRSKSP | 261 | Q12873 | |
| VKKPGKRGRKPAKID | 11 | O60519 | |
| ASKKAGPKSSPRKPV | 541 | Q8IZC6 | |
| PGHKKRGPSKKKPGA | 466 | Q96QF7 | |
| RGPSKKKPGAAKVEK | 471 | Q96QF7 | |
| EGKPKAKKAGAAKPR | 116 | P16402 | |
| AKKAGAAKPRKPAGA | 121 | P16402 | |
| AAKPRKPAGAAKKPK | 126 | P16402 | |
| KPAGAAKKPKKVAGA | 131 | P16402 | |
| KTKEGKGPNARRKPK | 261 | Q14839 | |
| KKIPGKRSPRSKKGT | 106 | Q6PJW8 | |
| KRSPRSKKGTAKKIP | 111 | Q6PJW8 | |
| KSGKGLKTCKSPGRK | 331 | P51608 | |
| VPKAKKKAPLAKGGR | 231 | P35269 | |
| SPPKKKNKASGRRSK | 76 | Q8TAD8 | |
| PKKTTTPKGKGRGAK | 1531 | Q02880 | |
| TPKGKGRGAKKRKAS | 1536 | Q02880 | |
| ARTPRSKKKKKLGAG | 1356 | Q13428 | |
| KPLKRFKRAAGKKGA | 386 | Q15345 | |
| KPKRKRTGSDSKSGK | 281 | Q15270 | |
| PLRAPKKTPGKKTGK | 461 | A6NCM1 | |
| ASKGKPRLPKASPKA | 1501 | Q9NTG1 | |
| KRKKSPEKGRAAPKT | 171 | Q9C0A6 | |
| KDRRAKGTPKSSKPG | 31 | Q86UG4 | |
| KRARKGKPKREDPKG | 296 | Q99457 | |
| QGSETAGPPKKKRKK | 36 | O75683 | |
| KKGGNYKKRKRSPSP | 291 | Q8TAQ2 | |
| GNKKTSKRSSKGRKP | 81 | Q15424 | |
| PGKSPSKKKKKFRTP | 711 | P35611 | |
| TRQFKSKPPKKGVKG | 31 | Q13956 | |
| KASTAKKGKPGRKAR | 386 | Q8IZ63 | |
| PKSKKKSRKGRPRKT | 156 | Q8IWS0 | |
| RPKKSKGKKAASRGP | 296 | Q12816 | |
| KKSKARPKSGRKSGS | 711 | O15066 | |
| KRAAPDSGKKPKTPK | 231 | O15405 | |
| PPAAKRRKTDTKGKK | 66 | A6NLC8 | |
| KLGPGKGSRKKRSLP | 946 | Q00722 | |
| GAKKRAAPKGTKRDP | 1431 | P11388 | |
| KRPSADPGKKAKNPK | 231 | Q96NM4 | |
| AGGEPDAPKKKKKRL | 791 | Q9NUA8 |